Evidence map›Paper›PMID 42109528›Full record

ReviewFrontiers in molecular biosciences2026

The "cutting edge" of non-canonical RNA splicing.

Jiusi Guo

Abstract readReview
In one paragraph

Review in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. DecipheringGenes · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Jiusi GuoDepartment of Biology, Georgia State University, Atlanta, GA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Splicing, including alternative splicing, is a fundamental post-transcriptional mechanism in eukaryotes that generates functional proteins and transcript diversity. Canonical splicing follows well-defined rules, such as sufficient intron and exon lengths, specific splice junction orientations, consensus dinucleotides at donor and acceptor sites, and mediation by the spliceosome. However, certain splicing events deviate from these canonical rules. This review synthesizes multiple forms of non-canonical splicing within a framework that reflects their increasing deviation from canonical mechanisms, including non-canonical splice sites, non-canonical splicing in lncRNAs, microexons, recursive splicing, trans-splicing, and spliceosome-independent splicing. In addition, this review provides a critical analysis of the current state of research for each form of non-canonical splicing and outlines key directions for future investigation. As a case study, we reanalyzed RNA-seq data from mouse neuronal cells to further examine non-canonical splice sites. These analyses show that non-canonical introns tend to be shorter and that many non-canonical junctions retain at least one canonical donor or acceptor dinucleotide, supporting the view that a substantial subset remains compatible with spliceosome-mediated recognition. Together, this review provides a structured perspective on how canonical splicing rules can be relaxed, repurposed, or bypassed across distinct biological contexts.

Indexed as

alternative splicingcircular RNAmicroexonsnon-canonical splice sitesnon-canonical splicingrecursive splicingspliceosome-independent splicingtrans-splicing

Identifiers

PMID42109528
PMCPMC13149111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.